A Randomized, Double-blind, Parallel-group Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus (T1DM) Compared to Placebo
Phase of Trial: Phase III
Latest Information Update: 18 Mar 2019
Price : $35 *
At a glance
- Drugs Dasiglucagon (Primary)
- Indications Hypoglycaemia
- Focus Registrational; Therapeutic Use
- Sponsors Zealand Pharma
- 13 Mar 2019 Status changed from recruiting to completed.
- 02 Nov 2018 Status changed from not yet recruiting to recruiting.
- 04 Oct 2018 New trial record